Showing results (311-320 of 938) with videos related to
Sort By:
Pageof 94
Diabetologia|December 6, 1997
Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II studyE J Brunner, M G Marmot, K Nanchahal, et al.Journal of Epidemiology and Community Health|December 12, 2000
Decline of the relative risk of death associated with low employment grade at older age: the impact of age related differences in smoking, blood pressure and plasma cholesterolP J Marang-van de Mheen, M J Shipley, J C Witteman, et al.South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|December 8, 1984
Absence of evidence of myocarditis in endomyocardial biopsy specimens from patients with dilated (congestive) cardiomyopathyA G Rose, R C Fraser, W BeckSouth African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|September 22, 1984
Sudden death of a champion athlete. Autopsy findingsT D Noakes, A G Rose, J BenjaminGynecologic Oncology|July 31, 2007
Avoiding bevacizumab related gastrointestinal toxicity for recurrent ovarian cancer by careful patient screeningFiona Simpkins, Jerome L Belinson, Peter G RoseCardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|May 21, 2015
Pathology of chronic cardiac rejection: An analysis of the epicardial and intramyocardial coronary arteries and myocardial alterations in 43 human allograftsA G Rose, L Viviers, J A OdellThorax|February 1, 1978
Calcification of glutaraldehyde-fixed porcine xenograftA G Rose, R Forman, R M BowenGynecologic Oncology|July 1, 1996
Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group StudyP G Rose, J A Blessing, J ArseneauGynecologic Oncology|February 27, 2010
Assessment of tumor response as a surrogate endpoint of survival in recurrent/platinum-resistant ovarian carcinoma: a Gynecologic Oncology Group studyPeter G Rose, Chunqiao Tian, Michael A BookmanAtherosclerosis|May 1, 1976
Clofibrate-induced low density liporotein elevation. Therapeutic implications and treatment by colestipol resinH G Rose, G K Haft, J JulianoPageof 94